Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricky Frazer

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
BMJ Case Reports|June 19, 2012
A simple chest drain gone wrong: a near miss!Ricky Frazer, Crawford Deane, Ramsey Sabit
Cureus|February 11, 2026
Hemophagocytic Lymphohistiocytosis Secondary to Immunotherapy Toxicity in a Patient With Breast Cancer: A Case ReportAbdullah Alhouri, Hari Johal, Ricky Frazer
BMJ Supportive & Palliative Care|March 20, 2014
An exploration of the word 'palliative' in the 19th century: searching the BMJ archives for cluesMark Taubert, Helen Fielding, Emma Mathews, et al.
BMJ Case Reports|July 11, 2012
A rare complication with a single dose of alendronateSrinivasa Munigoti, Ricky Frazer, Alan Rees, et al.
Cureus|March 30, 2026
A Case of Metastatic Melanoma Refractory to Immunotherapy: Is Cytotoxic Chemotherapy Still an Effective Option?Maleeha Anwar, Ricky Frazer, G J Melendez-Torres, et al.
BMJ (Clinical Research Ed.)|December 20, 2019
Bend it like Beckham or fix them like Florence-proportional representation of healthcare in New Year honours: an observational studyJohn A Emelifeonwu, James E Hazelwood, Oscar Nolan, et al.
Therapeutic Advances in Medical Oncology|November 7, 2022
Delphi panel for consensus on the optimal management of dabrafenib plus trametinib-related pyrexia in patients with melanomaRicky Frazer, Avinash Gupta, Christopher Herbert, et al.
Oncology and Therapy|May 31, 2025
Clinical Management and Outcomes of Immune-Related Adverse Events During Treatment with Immune Checkpoint Inhibitor Therapies in Melanoma and Renal Cell Carcinoma: A UK Real-World Evidence StudyAnna Olsson-Brown, Ankit Jain, Ricky Frazer, et al.
Clinical Genitourinary Cancer|March 27, 2026
Real-World Outcomes of First-Line Ipilimumab Plus Nivolumab in Advanced Renal Cell Carcinoma: A UK Multi-Centre Retrospective StudyBenjamin Thomas Crosby, Steffanie Winsor, Alice Spurr, et al.
International Journal of Cancer|February 7, 2026
International analysis of reimbursement rates and clinical benefit of genitourinary cancer drugs across Canada, France, England, Wales, Scotland, Spain, Italy, and PortugalJose C Tapia, Javier Gavira, Diana Matthews, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
BMJ Case Reports|June 19, 2012
A simple chest drain gone wrong: a near miss!Ricky Frazer, Crawford Deane, Ramsey Sabit
Cureus|February 11, 2026
Hemophagocytic Lymphohistiocytosis Secondary to Immunotherapy Toxicity in a Patient With Breast Cancer: A Case ReportAbdullah Alhouri, Hari Johal, Ricky Frazer
BMJ Supportive & Palliative Care|March 20, 2014
An exploration of the word 'palliative' in the 19th century: searching the BMJ archives for cluesMark Taubert, Helen Fielding, Emma Mathews, et al.
BMJ Case Reports|July 11, 2012
A rare complication with a single dose of alendronateSrinivasa Munigoti, Ricky Frazer, Alan Rees, et al.
Cureus|March 30, 2026
A Case of Metastatic Melanoma Refractory to Immunotherapy: Is Cytotoxic Chemotherapy Still an Effective Option?Maleeha Anwar, Ricky Frazer, G J Melendez-Torres, et al.
BMJ (Clinical Research Ed.)|December 20, 2019
Bend it like Beckham or fix them like Florence-proportional representation of healthcare in New Year honours: an observational studyJohn A Emelifeonwu, James E Hazelwood, Oscar Nolan, et al.
Therapeutic Advances in Medical Oncology|November 7, 2022
Delphi panel for consensus on the optimal management of dabrafenib plus trametinib-related pyrexia in patients with melanomaRicky Frazer, Avinash Gupta, Christopher Herbert, et al.
Oncology and Therapy|May 31, 2025
Clinical Management and Outcomes of Immune-Related Adverse Events During Treatment with Immune Checkpoint Inhibitor Therapies in Melanoma and Renal Cell Carcinoma: A UK Real-World Evidence StudyAnna Olsson-Brown, Ankit Jain, Ricky Frazer, et al.
Clinical Genitourinary Cancer|March 27, 2026
Real-World Outcomes of First-Line Ipilimumab Plus Nivolumab in Advanced Renal Cell Carcinoma: A UK Multi-Centre Retrospective StudyBenjamin Thomas Crosby, Steffanie Winsor, Alice Spurr, et al.
International Journal of Cancer|February 7, 2026
International analysis of reimbursement rates and clinical benefit of genitourinary cancer drugs across Canada, France, England, Wales, Scotland, Spain, Italy, and PortugalJose C Tapia, Javier Gavira, Diana Matthews, et al.
Pageof 2